Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Banyu patents new series of NPY antagonists for obesity, bulimia, diabetes

Oct. 6, 1998

New collaboration into the genetic basis of obesity announced

Oct. 5, 1998

Icos and Lilly join forces to develop PDE5 inhibitors for sexual dysfunction

Oct. 2, 1998

Ono describes new prostanoid receptor ligands

Oct. 2, 1998

Rhone-Poulenc Rorer's CombiPatch now available in the U.S.

Oct. 1, 1998

Gene Activated erythropoietin enters phase III clinical trials

Oct. 1, 1998

Lilly and Dura collaborate to develop pulmonary delivery of insulin

Oct. 1, 1998

Merck & Co. designs orally active beta3-adrenoceptor partial agonists

Sep. 30, 1998

First orally active, nonsteroidal antiprogestins reported by Ligand

Sep. 29, 1998

Novo Nordisk discontinues development of osteoporosis drug

Sep. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...